Windlas Biotech Ltd
BSE:543329
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Windlas Biotech Ltd
BSE:543329
|
IN |
|
Rackspace Technology Inc
NASDAQ:RXT
|
US |
|
Travis Perkins PLC
LSE:TPK
|
UK |
|
O
|
Oshkosh Corp
F:OK3
|
US |
|
Logista Integral SA
MAD:LOG
|
ES |
|
S
|
Sabaf SpA
SWB:SM5
|
IT |
|
G
|
Goldstorm Metals Corp
F:B2U
|
CA |
|
K
|
Kerry Properties Ltd
F:KR3
|
HK |
|
N
|
Nanjing Panda Electronics Co Ltd
XMUN:NNJ
|
CN |
Intrinsic Value
Is WINDLAS undervalued or overvalued?
See the intrinsic value estimate for 
Windlas Biotech Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
WINDLAS looks undervalued.
But is it cheap by its own standards?
See how today’s valuation compares with WINDLAS’s past valuations and how the stock performed after similar periods.
Fundamental Analysis
What Windlas Biotech Does
Windlas Biotech makes finished pharmaceutical products for other drug companies and also sells its own branded medicines in India. Its core work is contract development and manufacturing of tablets, capsules, and other solid-dose medicines, where customers hire Windlas to develop a formula, manufacture the product, and package it under the customer’s brand. It also supplies selected products through its own domestic distribution network, which gives it a mix of contract and branded business.
- Headquarters
- India IN
- IPO date
- Aug 16, 2021
Earnings Waterfall
Windlas Biotech Ltd
The intrinsic value for Windlas Biotech Ltd (543329) under the Base Case is hidden INR.
Compared with the current market price of 898.55 INR, the stock appears hidden.